Neonatal Symptoms After In Utero Exposure to SSRIs - MGH Center

The increasing number of reproductive-age women taking antidepressants has raised concerns about the potential risks of using these medications during pregnancy. Literature accumulated over the last decade supports the use of certain selective serotonin reuptake inhibitors (SSRIs) and the older tricyclic antidepressants during pregnancy, indicating no increased risk of congenital malformation in children exposed to these medications during the first trimester of pregnancy. Still, questions remain regarding the purported risk for "toxicity" in newborns exposed to antidepressants around the time of labor and delivery. These concerns are not new. Twenty years ago, case reports suggested that maternal use of tricyclic antidepressants near the time of delivery was associated with problems in the newborn such as difficulty feeding, restlessness, or jitteriness.

Antidepressants in Pregnancy Tied to Health Risks for Kids

IJERPH, Free Full-Text

Prenatal antidepressant exposure and emotional disorders until age 22: a danish register study, Child and Adolescent Psychiatry and Mental Health

Antidepressants During Breastfeeding - Psychopharmacology Institute

prenatal SSRI exposure - MGH Center for Women's Mental Health

Antidepressant use during pregnancy and the risk of preterm birth – a cohort study

Managing psychiatric illness during pregnancy and breastfeeding: Tools for decision making

Anxiety and Depression: Understanding the Risk for Preeclampsia - Page 2 of 2

Antidepressants During Breastfeeding - Psychopharmacology Institute

Evaluating the Long-Term Effects of Prenatal Antidepressant

Intrauterine Drug Exposure and the Management of Neonatal Abstinence Syndrome

Frontiers Sudden Onset of Severe Pulmonary Hypertension in a Preterm Infant: A Case Report on the Role of Maternal Use of Serotonin Re-Uptake Inhibitors During Pregnancy and Concurrent Risk Factors

PPT - Neonatal Adverse Events Associated with in utero SSRI/SNRI